Thomas Gaberel1, Clement Gakuba1, Romain Goulay1, Sara Martinez De Lizarrondo1, Jean-Luc Hanouz1, Evelyne Emery1, Emmanuel Touze1, Denis Vivien1, Maxime Gauberti2. 1. From INSERM, INSERM UMR-S U919, Serine Proteases and Pathophysiology of the Neurovascular Unit, GIP Cyceron, University Caen, Caen, France (T.G., C.G., R.G., S.M.D.L., E.E., E.T., D.V., M.G.); and Departments of Neurosurgery (T.G., E.E.), Anesthesiology and Critical Care Medicine (C.G., J.-L.H.), and Neurology (E.T.), Caen University Hospital, Caen, France. 2. From INSERM, INSERM UMR-S U919, Serine Proteases and Pathophysiology of the Neurovascular Unit, GIP Cyceron, University Caen, Caen, France (T.G., C.G., R.G., S.M.D.L., E.E., E.T., D.V., M.G.); and Departments of Neurosurgery (T.G., E.E.), Anesthesiology and Critical Care Medicine (C.G., J.-L.H.), and Neurology (E.T.), Caen University Hospital, Caen, France. gauberti@cyceron.fr.
Abstract
BACKGROUND AND PURPOSE: The aim of the present study was to investigate the impact of different stroke subtypes on the glymphatic system using MRI. METHODS: We first improved and characterized an in vivo protocol to measure the perfusion of the glymphatic system using MRI after minimally invasive injection of a gadolinium chelate within the cisterna magna. Then, the integrity of the glymphatic system was evaluated in 4 stroke models in mice including subarachnoid hemorrhage (SAH), intracerebral hemorrhage, carotid ligature, and embolic ischemic stroke. RESULTS: We were able to reliably evaluate the glymphatic system function using MRI. Moreover, we provided evidence that the glymphatic system was severely impaired after SAH and in the acute phase of ischemic stroke, but was not altered after carotid ligature or in case of intracerebral hemorrhage. Notably, this alteration in glymphatic perfusion reduced brain clearance rate of low-molecular-weight compounds. Interestingly, glymphatic perfusion after SAH can be improved by intracerebroventricular injection of tissue-type plasminogen activator. Moreover, spontaneous arterial recanalization was associated with restoration of the glymphatic function after embolic ischemic stroke. CONCLUSIONS: SAH and acute ischemic stroke significantly impair the glymphatic system perfusion. In these contexts, injection of tissue-type plasminogen activator either intracerebroventricularly to clear perivascular spaces (for SAH) or intravenously to restore arterial patency (for ischemic stroke) may improve glymphatic function.
BACKGROUND AND PURPOSE: The aim of the present study was to investigate the impact of different stroke subtypes on the glymphatic system using MRI. METHODS: We first improved and characterized an in vivo protocol to measure the perfusion of the glymphatic system using MRI after minimally invasive injection of a gadolinium chelate within the cisterna magna. Then, the integrity of the glymphatic system was evaluated in 4 stroke models in mice including subarachnoid hemorrhage (SAH), intracerebral hemorrhage, carotid ligature, and embolic ischemic stroke. RESULTS: We were able to reliably evaluate the glymphatic system function using MRI. Moreover, we provided evidence that the glymphatic system was severely impaired after SAH and in the acute phase of ischemic stroke, but was not altered after carotid ligature or in case of intracerebral hemorrhage. Notably, this alteration in glymphatic perfusion reduced brain clearance rate of low-molecular-weight compounds. Interestingly, glymphatic perfusion after SAH can be improved by intracerebroventricular injection of tissue-type plasminogen activator. Moreover, spontaneous arterial recanalization was associated with restoration of the glymphatic function after embolic ischemic stroke. CONCLUSIONS:SAH and acute ischemic stroke significantly impair the glymphatic system perfusion. In these contexts, injection of tissue-type plasminogen activator either intracerebroventricularly to clear perivascular spaces (for SAH) or intravenously to restore arterial patency (for ischemic stroke) may improve glymphatic function.
Authors: Amanda M Sweeney; Virginia Plá; Ting Du; Guojun Liu; Qian Sun; Sisi Peng; Benjamin A Plog; Benjamin T Kress; Xiaowei Wang; Humberto Mestre; Maiken Nedergaard Journal: J Vis Exp Date: 2019-07-29 Impact factor: 1.355
Authors: Benjamin A Plog; Humberto Mestre; Genaro E Olveda; Amanda M Sweeney; H Mark Kenney; Alexander Cove; Kosha Y Dholakia; Jeffrey Tithof; Thomas D Nevins; Iben Lundgaard; Ting Du; Douglas H Kelley; Maiken Nedergaard Journal: JCI Insight Date: 2018-10-18
Authors: Humberto Mestre; Ting Du; Amanda M Sweeney; Guojun Liu; Andrew J Samson; Weiguo Peng; Kristian Nygaard Mortensen; Frederik Filip Stæger; Peter A R Bork; Logan Bashford; Edna R Toro; Jeffrey Tithof; Douglas H Kelley; John H Thomas; Poul G Hjorth; Erik A Martens; Rupal I Mehta; Orestes Solis; Pablo Blinder; David Kleinfeld; Hajime Hirase; Yuki Mori; Maiken Nedergaard Journal: Science Date: 2020-01-30 Impact factor: 47.728
Authors: Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw Journal: Cardiovasc Res Date: 2018-09-01 Impact factor: 10.787